To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2995 | L-663581 |
Novel partial agonist of the benzodiazepine receptor
More description
|
|
| DCC2994 | L-658758 |
Blocker of the activity of human neutrophil elastase (NE), human proteinase-3, human macrophage metalloelastase, mouse macrophage metalloelastase and Pseudomonas aeruginosa elastase
More description
|
|
| DCC2993 | L-651392 |
Potent leukotriene inhibitor
More description
|
|
| DCC2992 | L61h46 |
Novel potent inhibitor of human pancreatic cancer cells
More description
|
|
| DCC2991 | L524-0366 |
Novel inhibitor of the TWEAK-Fn14 signaling cascade
More description
|
|
| DCC2990 | L465046 (α-synuclein Amyloid Aggregation Inhibitor) |
Novel inhibitor of α-synuclein amyloid aggregation for the treatment of Parkinson's disease
More description
|
|
| DCC2989 | L458-bpyne |
Novel γ-secretase modulator photoaffinity probe, identifying distinct allosteric binding sites on presenilin that can be exploited to reduce levels of pathogenic Aβ species
More description
|
|
| DCC2988 | L2-4048 |
Novel Migration Inhibitory Factor (MIF) inhibitor, binding at the allosteric and tautomerase sites, blocking MIF's tautomerase CD74 receptor binding, and pro-inflammatory activities
More description
|
|
| DCC2987 | L17er4 |
Novel cell-permeable attenuated cationic amphiphilic lytic (ACAL) peptide, efficiently bring immunoglobulin G (IgG) and other functional proteins into cells
More description
|
|
| DCC2986 | L-162782 |
Nonpeptide agonist of angiotensin AT1 receptor
More description
|
|
| DCC2985 | L-161240 |
Potent inhibitor of LpxC and lipid A biosynthesis
More description
|
|
| DCC2984 | Kys05047 |
Selective T-type Ca(2+) channel blocker with anti-proliferative effects against various cancer cells
More description
|
|
| DCC2983 | Kya1797 |
Novel inhibitor of the Wnt/ß-catenin pathway, binding directly to the regulators of G-protein signaling domain of axin, initiating ß-catenin and Ras degradation through enhancement of the ß-catenin destruction complex activating GSK3ß, effectively suppres
More description
|
|
| DCC2982 | Ky1022 |
Ras destabilizer, targeting the Wnt/ß-catenin pathway and inhibiting development of metastatic colorectal cancer
More description
|
|
| DCC2981 | Kva-d-88 |
Novel Preferable Phosphodiesterase 4B (PDE4B) Inhibitor, Decreasing Cocaine-Mediated Reward Properties in Vivo
More description
|
|
| DCC2980 | Kv2.1/syntaxin-in-cpd5 |
Novel neuroprotectant, inhibiting Kv2.1-syntaxin molecular interaction
More description
|
|
| DCC2979 | kv1.5-in-iiii |
Potent Kv1.5 inhibitor
More description
|
|
| DCC2978 | Kurasoin B |
Novel protein farnesyltransferase inhibitor
More description
|
|
| DCC2977 | Kunb31 |
Novel potent and selective inhibitor of Hsp90β
More description
|
|
| DCC2976 | Kufal194 |
Novel selective DYRK1A inhibitor
More description
|
|
| DCC2975 | Ku-2285 |
Hypoxic cell radiosensitizer
More description
|
|
| DCC2974 | Kta-439 |
Thyroid hormone receptor β (TRβ) selective agonist
More description
|
|
| DCC2973 | Kt2-962 |
TXA2/prostaglandin endoperoxide receptor antagonist
More description
|
|
| DCC2972 | Kt-182 |
Potent and selective inhibitor of ABHD6
More description
|
|
| DCC2971 | Kspa-1 |
Novel modulator of kinesin spindle protein (KSP)/Eg5, activating KSP-catalyzed ATP hydrolysis in the absence of microtubules yet inhibiting microtubule-stimulated ATP hydrolysis by KSP
More description
|
|
| DCC2970 | Ksl-128114 |
Novel, highly potent, and metabolically stable peptide inhibitor of syntenin, Inhibiting Glioblastoma
More description
|
|
| DCC2969 | Ksk120 |
Novel inhibitor of transcriptional activity in Chlamydia trachomatis
More description
|
|
| DCC2968 | kscm-5 |
Ligand of the sigma receptor
More description
|
|
| DCC2967 | Kscm-11 |
Ligand of the sigma receptor
More description
|
|
| DCC2966 | kscm-1 |
Selective ligand of the sigma-1 receptor
More description
|
|